XML 18 R4.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Consolidated Statements of Operations - USD ($)
 12 Months Ended
Mar. 31, 2024
Mar. 31, 2023
Mar. 31, 2022
Consolidated Statements of Operations [Abstract]      
Net sales $ 717,684,000 $ 683,074,000 $ 650,308,000
Cost of goods sold 585,133,000 569,112,000 532,443,000
Gross profit 132,551,000 113,962,000 117,865,000
Operating expenses:      
General and administrative 57,769,000 54,756,000 57,499,000
Sales and marketing 22,481,000 21,729,000 22,833,000
Research and development 9,995,000 10,322,000 10,502,000
Foreign exchange impact of lease liabilities and forward contracts (3,814,000) (9,291,000) (1,673,000)
Total operating expenses 86,431,000 77,516,000 89,161,000
Operating income 46,120,000 36,446,000 28,704,000
Other expenses:      
Interest expense, net 60,040,000 39,555,000 15,555,000
Change in fair value of compound net derivative liability (1,020,000) 0 0
Loss on extinguishment of debt 168,000 0 0
Total other expenses 59,188,000 39,555,000 15,555,000
(Loss) income before income tax expense (13,068,000) (3,109,000) 13,149,000
Income tax expense 36,176,000 1,098,000 5,788,000
Net (loss) income $ (49,244,000) $ (4,207,000) $ 7,361,000
Basic net (loss) income per share (in dollars per share) $ (2.51) $ (0.22) $ 0.38
Diluted net (loss) income per share (in dollars per share) $ (2.51) $ (0.22) $ 0.38
Weighted average number of shares outstanding:      
Basic (in shares) 19,601,204 19,340,246 19,119,727
Diluted (in shares) 19,601,204 19,340,246 19,559,646